No Turnaround for the Chemical Industry

Melanie Steinbeck,

The German Chemical Industry Association Warns of Persistent Weakness in Investment

Although the German chemical and pharmaceutical industry slowed its decline in the first half of 2026, a recovery is not in sight, according to the German Chemical Industry Association (VCI). Production was down about 3.0 percent from the previous year, and revenue fell by 1.0 percent to 106 billion euros. At the same time, investments have been declining for the third consecutive year—which the industry association views as the real warning sign.

Pictured from left: Dr. Markus Steilemann, President of the German Chemical Industry Association (VCI) and CEO of Covestro AG; Dr. Wolfgang Große Entrup, Managing Director of the © VCI / Thomas Lohnes

“We are merely experiencing a respite, not a turnaround,” said VCI President Markus Steilemann during the presentation of the midyear report. Although the first half of the year performed better than the second half of the previous year, this is not enough to signal a sustained recovery.

Special geopolitical factors are supporting domestic business

The VCI attributes this slight stabilization primarily to one-time geopolitical factors. As a result of the armed conflicts in the Middle East, companies reportedly increased their inventory levels to prevent potential supply disruptions. At the same time, the temporary closure of the Strait of Hormuz has temporarily eased competitive pressure from Asian suppliers.

Domestic business benefited most of all. Domestic sales rose by 2.0 percent to 40 billion euros in the first half of the year. Export business, on the other hand, continued to perform weakly. Foreign sales fell by 2.5 percent to 66 billion euros. According to the VCI, many production facilities continue to operate below capacity. Production and sales remain well below 2021 levels.

Advertisement

The chemical industry has been hit harder than the pharmaceutical industry

Economic performance varied within the sector. Production fell by 3.0 percent in the chemical industry and by 1.5 percent in the pharmaceutical industry. The decline in revenue was also smaller in the pharmaceutical industry (0.5 percent) than in the chemical industry. At the same time, the VCI points out that business conditions are now deteriorating for pharmaceutical companies as well.

The decline in production was particularly pronounced for petrochemicals and their derivatives, at minus 5.5 percent. Polymers were down 4.0 percent from the previous year. Declines were also recorded for laundry and personal care products as well as cosmetics (-3.5 percent), fine and specialty chemicals (-1.5 percent), and pharmaceuticals (-1.5 percent). The production of inorganic basic chemicals remained relatively stable (-0.5 percent).

The number of employees decreased by 1.0 percent in the first half of the year to approximately 471,500.

Earnings remain under pressure

The weak production figures are also reflected in companies’ expectations. According to a VCI member survey, 47 percent of companies expect their revenues to decline in 2026. Another 22 percent expect no change. Only 31 percent anticipate an improvement in their economic situation.

Rising costs, low sales volumes, and intense international competition are likely to keep pressure on margins high in the coming months as well. For the year as a whole, the association continues to expect a 1.5 percent decline in production. The VCI is refraining from making further forecasts in light of the ongoing geopolitical volatility.

Investments are becoming the real problem for the location

The association is more concerned about investment trends than about the current economic situation. According to the VCI, investment in property, plant, and equipment is now about 15 percent below the 2023 level. This marks the third consecutive year of decline.

International comparisons also paint a sobering picture. According to a McKinsey analysis cited by the VCI, net productive investment in Germany amounts to only about 0.2 percent of economic output. This places Germany at the bottom of the list of industrial locations considered in an international comparison. At the same time, production capacity is also being reduced in Europe without sufficient investment in new facilities or future technologies.

Companies’ investment plans reflect this trend. Forty-five percent of the companies surveyed plan to reduce their investments in Germany. Abroad, however, expansion plans predominate. Foreign locations are also becoming more attractive for research and development.

The chemical and pharmaceutical industries are increasingly investing internationally: The chart shows the planned investments and research and development activities of the chemical and pharmaceutical industries in 2026, comparing Germany with other countries. © VCI

The trend is even more pronounced in research and development. While only 19 percent of companies in Germany plan to expand their R&D activities and 29 percent expect a decline, the focus is increasingly shifting abroad. There, 41 percent intend to expand their research and development activities, while only 11 percent expect a decline. The survey thus suggests that not only investments but also innovation activities are increasingly concentrated outside of Germany.

Companies See Disadvantages of Their Location

Companies cite high location costs as the biggest barriers to investment. 86 percent of respondents view them as a decisive disadvantage. This is followed by energy and climate policy (81 percent), what they perceive as a lack of reliability in industrial policy (61 percent), increasing import pressure (53 percent), and a lack of reforms (51 percent).

Consequently, the assessment of the political framework is critical. More than 80 percent of companies believe that the risks of deindustrialization are not being adequately addressed at the political level. The VCI is therefore calling for, among other things, more competitive corporate taxes, lower labor costs, faster permitting procedures, and further reductions in bureaucracy.

According to VCI President Markus Steilemann, the federal government’s reform package is “the first serious attempt in years” to strengthen Germany as an industrial hub. However, he noted that the key factor will be whether it leads to long-term structural reforms and does not impose additional burdens on industry.

What the Chemical Industry Figures Mean for the Industry

The performance of the chemical industry is traditionally regarded as a leading indicator of industrial economic conditions. So do the current signals extend beyond this sector? The ongoing reluctance to invest and high cost pressures highlight the challenges many industrial companies are currently facing. At the same time, there is a growing need to use existing production capacities more efficiently. Automation, digitalization, and data-driven process optimization are thus becoming increasingly important—not only in the chemical industry, but throughout the entire industrial value chain.

  • Xing Icon
  • LinkedIn Icon
Advertisement
Advertisement

You might also be interested in

Advertisement
Advertisement
Advertisement
Advertisement

Chemical industry 2026

Why the crisis continues

How deep is Germany's chemical industry really in crisis in 2026? After a weak start to the year, burdened by the conflict in the Middle East, high energy costs and global competitive pressure, the German Chemical Industry Association (VCI) paints a...

read more...
Advertisement
Advertisement
Advertisement

3D printing

Stratasys takes over MarkForged

Stratasys is acquiring MarkForged from Nano Dimension for USD 42.5 million, thereby expanding its portfolio in the field of fiber-reinforced composites. The acquisition also strengthens the company's software and materials expertise in industrial 3D...

read more...
Subscribe to our newsletter
Advertisement
Back to home